Use of Celontin in the Treatment of Mixed Epilepsy

Abstract
Celontin was used in the treatment of epilepsy in 16 patients for a period of 3-17 months. Reduction in number of seizures was obtained in petit mal, grand mal, and psychomotor epilepsy. All but 1 patient received benefit and some very marked benefit. There were no significant toxic reactions nor side effects with therapy.

This publication has 2 references indexed in Scilit: